İstanbul Journal of Pharmacy

GÖNDERBİLGİ
EnglishTürkçe

Araştırma Makalesi


DOI :10.26650/IstanbulJPharm.2019.19042   IUP :10.26650/IstanbulJPharm.2019.19042    Tam Metin (PDF)

The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents

Zeliha Pala Kara, Büşra Çakır, Deniz Kaleli Durman, Birsel Sönmez Uydeş Doğan

Autism spectrum disorder (ASD) is one of the neuropsychiatric disorders of childhood and has many causes including genetic, neurobiological, environmental, as well as other risk factors that can trigger the disorder. The aim of this survey is to determine the knowledge of the families about ASD, the most prescribed medications, their side effects and the alternative therapies used besides to the pharmacological treatment. This study was survey-based and conducted among parents of children with ASD (N=50). Risperidone, aripiprazole, and valproate were the most prescripted drugs (64%) and weight gain (n=14), increased aggressive behavior (n=11) and drowsiness/sedation (n=11) were reported as the main side effects. Besides to pharmacological therapy, most of ASD children have used complementary and alternative medicine like gluten and caseinfree diet (n =23) or the sugar diet (n=15), as well as omega-3 (n=43), multivitamins (n=40), heavy metal chelation agents (n=27), vitamin B12 (n=18), zinc (n=17) vitamin D (n=9), and probiotics (n= 7). It is revealed that pharmacists should be able to inform the parents about the general characteristics of ASD, and new treatment approaches, and provide a rational use of prescribed drugs in children with autism.

Anahtar Kelimeler: Autism spectrum disorder, pharmacist role, pharmacological therapy, complemenatry and alternative medicine

PDF Görünüm

Referanslar

  • Aman MG, Farmer CA, Hollway J, Arnold LE (2008). Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 17: 713-738. google scholar
  • Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, et. al. (2018) Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network. MMWR Surveill Summ 67: 1-23. google scholar
  • Baumer N, Spence SJ (2018). Evaluation and Management of the Child With Autism Spectrum Disorder. Continuum (Minneap Minn) 24: 248-275. google scholar
  • Bolton P, Macdonald H, Pickles A, Rios P, Goode S, Crowson M, Bailey A, Rutter M (1994). A case-control family history study of autism. J Child Psychol Psychiatry 35: 877-900. google scholar
  • Breik N, Kuo IF, Bugden S, Moffat M, Alessi-Severini S (2018). Treating Children with ASD: The Perspective of Caregivers. J Pharm Pharm Sci 21: 74-87. google scholar
  • Cattane N, Richetto J, Cattaneo A (2018). Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms. Neurosci Biobehav Rev 7634: 30972-30977. google scholar
  • Christensen D L, Baio J, Van Naarden BK, Bilder D, Charles J, Constantino J N, et al. (2016) Centers for Disease Control and Prevention Prevalence and characteristics of autismspectrumdisorder among children aged 8 years-Autismand Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveillance Summaries 65: 1-23. google scholar
  • Davis TN, O-Reilly M, Kang S, et al. (2012) Chelation treatment for autism spectrum disorders: a systematic review. Res Autism Spectr Disord 7: 49-55. google scholar
  • DeFilippis M. (2018) The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder. Psychopharmacol Bull 48: 40-63. google scholar
  • DiGuiseppi C, Hepburn S, Davis JM, Fidler DJ, Hartway S, Lee N.R, et al. (2010) Screening for autism spectrum disorders in children with down syndrome. J Dev Behav Pediatr 31: 181-191. google scholar
  • Emberti Gialloreti L, Mazzone L, Benvenuto A, Fasano A, Alcon AG, Kraneveld A, et al.(2019) Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations. J Clin Med 8: 217-240. google scholar
  • Goel R, Hong JS, Findling RL, Ji NY. (2018) An update on pharmacotherapy of autism spectrum disorder in children and adolescents. Int Rev Psychiatry 30: 78-95. google scholar
  • Gyawali S and Patra BN.(2019) Autism spectrum disorder: Trends in research exploring etiopathogenesis. Psychiatry Clin Neurosci. 73: 466-475. google scholar
  • Hall SS, Lightbody AA, Reiss AL. (2008) Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. Am J Ment Retard 113: 44-53. google scholar
  • Hellings JA, Nickel EJ, Weckbaugh M, McCarter K, Mosier M, Schroeder SR. (2005) The overt aggression scale for rating aggression in outpatient youth with autistic disorder: preliminary findings. J Neuropsychiatry Clin Neurosci 17: 29-35. google scholar
  • Höfer J, Hoffmann F, Kamp-Becker I, Küpper C, Poustka L, Roepke S, et al. (2019) Complementary and alternative medicine use in adults with autism spectrum disorder in Germany: results from a multi-center survey. BMC Psychiatry 19: 53-61. google scholar
  • Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, et al. (2010) Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology 35: 990-998. google scholar
  • James S, Stevenson SW, Silove N, Williams K. (2015) Chelation for autism spectrum disorder (ASD). Cochrane Database Syst Rev Issue 5. Art. No.: CD010766. google scholar
  • Kawicka A, Regulska-Ilow B.(2013) How nutritional status, diet and dietary supplements can affect autism. A review. Rocz Panstw Zakl Hig 64: 1-12. google scholar
  • Lovato DV, Herai RR, Pignatari GC, Beltrão-Braga PCB. (2019) The Relevance of Variants With Unknown Significance for Autism Spectrum Disorder Considering the Genotype-Phenotype Interrelationship. Front Psychiatry 10: 409-415. google scholar
  • Luleci NE, Hidiroglu S, Karavus M, Karavus A, Sanver FF, Ozgur F, Celik M, Celik SC.(2016) The pharmacists’ awareness, knowledge and attitude about childhood autism in Istanbul. Int J Clin Pharm 38: 1477-1482. google scholar
  • National Institute of Mental Health (2018). Autism Spectrum Disorder. Retrieved from https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders google scholar
  • Novaes CM, Pondé MP, Freire AC. (2008) Control of psychomotor agitation and aggressive behavior in patients with autistic disorder: a retrospective chart review. Arq Neuropsiquiatr 66: 646-651. google scholar
  • Oshikoya KA, Carroll R, Aka I, Roden DM, Van Driest SL. (2019) Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study. Drugs Real World Outcomes 6: 59-71. google scholar
  • Pelch KE, Bolden AL, Kwiatkowski CF. (2019) Environmental Chemicals and Autism: A Scoping Review of the Human and Animal Research. Environ Health Perspect 127: 46001-46012. google scholar
  • Posey DJ, Stigler KA, Erickson CA, McDougle CJ. (2008) Antipsycohtics in the treatment of autism. J Clin Invest 118: 6-14. google scholar
  • Shafiq S, Pringsheim T. (2018) Using antipsychotics for behavioral problems in children. Expert Opin Pharmacother 19: 1475-1488. google scholar
  • Sharma SR, Gonda X, Tarazi FI. (2018) Autism Spectrum Disorder: Classification, diagnosis and therapy. Pharmacol Ther 190: 91-104. google scholar
  • Tye C, Runicles AK, Whitehouse AJO, Alvares GA. (2019) Characterizing the Interplay Between Autism Spectrum Disorder and Comorbid Medical Conditions: An Integrative Review. Front Psychiatry 9: 751-773. google scholar
  • Wink LK, Pedapati EV, Horn PS, McDougle CJ, Erickson CA. (2017) Multiple Antipsychotic Medication Use in Autism Spectrum Disorder. J Child Adolesc Psychopharmacol 27: 91-94. google scholar
  • Wongpakaran R, Suansanae T, Tan-Khum T, Kraivichian C, Ongarjsakulman R, Suthisisang C. (2017) Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study. J Clin Pharm Ther 42: 329-336. google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Pala Kara, Z., Çakır, B., Kaleli Durman, D., & Uydeş Doğan, B. (0001). The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents. İstanbul Journal of Pharmacy, 49(3), 180-185. https://doi.org/10.26650/IstanbulJPharm.2019.19042


AMA

Pala Kara Z, Çakır B, Kaleli Durman D, Uydeş Doğan B. The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents. İstanbul Journal of Pharmacy. 0001;49(3):180-185. https://doi.org/10.26650/IstanbulJPharm.2019.19042


ABNT

Pala Kara, Z.; Çakır, B.; Kaleli Durman, D.; Uydeş Doğan, B. The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents. İstanbul Journal of Pharmacy, [Publisher Location], v. 49, n. 3, p. 180-185, 0001.


Chicago: Author-Date Style

Pala Kara, Zeliha, and Büşra Çakır and Deniz Kaleli Durman and Birsel Sönmez Uydeş Doğan. 0001. “The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents.” İstanbul Journal of Pharmacy 49, no. 3: 180-185. https://doi.org/10.26650/IstanbulJPharm.2019.19042


Chicago: Humanities Style

Pala Kara, Zeliha, and Büşra Çakır and Deniz Kaleli Durman and Birsel Sönmez Uydeş Doğan. “The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents.” İstanbul Journal of Pharmacy 49, no. 3 (Nov. 2024): 180-185. https://doi.org/10.26650/IstanbulJPharm.2019.19042


Harvard: Australian Style

Pala Kara, Z & Çakır, B & Kaleli Durman, D & Uydeş Doğan, B 0001, 'The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents', İstanbul Journal of Pharmacy, vol. 49, no. 3, pp. 180-185, viewed 15 Nov. 2024, https://doi.org/10.26650/IstanbulJPharm.2019.19042


Harvard: Author-Date Style

Pala Kara, Z. and Çakır, B. and Kaleli Durman, D. and Uydeş Doğan, B. (0001) ‘The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents’, İstanbul Journal of Pharmacy, 49(3), pp. 180-185. https://doi.org/10.26650/IstanbulJPharm.2019.19042 (15 Nov. 2024).


MLA

Pala Kara, Zeliha, and Büşra Çakır and Deniz Kaleli Durman and Birsel Sönmez Uydeş Doğan. “The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents.” İstanbul Journal of Pharmacy, vol. 49, no. 3, 0001, pp. 180-185. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2019.19042


Vancouver

Pala Kara Z, Çakır B, Kaleli Durman D, Uydeş Doğan B. The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents. İstanbul Journal of Pharmacy [Internet]. 15 Nov. 2024 [cited 15 Nov. 2024];49(3):180-185. Available from: https://doi.org/10.26650/IstanbulJPharm.2019.19042 doi: 10.26650/IstanbulJPharm.2019.19042


ISNAD

Pala Kara, Zeliha - Çakır, Büşra - Kaleli Durman, Deniz - Uydeş Doğan, Birsel Sönmez. “The role of pharmacists in the management of autism spectrum disorder: A survey to determine the knowledge and perception of the parents”. İstanbul Journal of Pharmacy 49/3 (Nov. 2024): 180-185. https://doi.org/10.26650/IstanbulJPharm.2019.19042



ZAMAN ÇİZELGESİ


Kabul30.09.2019

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.